Literature DB >> 25337296

Autoimmune neutropenia preceding Helicobacter pylori-negative MALT lymphoma with nodal dissemination.

Saori Harada1, Sho Yamazaki1, Fumihiko Nakamura1, Ken Morita1, Akihide Yoshimi1, Aya Shinozaki-Ushiku2, Masashi Fukayama2, Mineo Kurokawa3.   

Abstract

Autoimmune neutropenia (AIN), resulting from granulocyte-specific autoantibodies, is much less frequent than other autoimmune hematologic disorders including autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). These autoimmune disorders may precede, synchronize, or follow collagen disorders, viral infections, and lymphoid neoplasms. Herein we present the first case of AIN in association with Helicobacter pylori-negative mucosa-associated lymphoid tissue (MALT) lymphoma with nodal dissemination. In our case, AIN, accompanied by ITP, occurred prior to the clinical manifestation of lymphoma. AIN and ITP were well managed afterwards, but they relapsed in accordance with the recurrence of lymphoma. The administration of prednisolone at 0.5 mg/kg daily alleviated the cytopenias within a week. In general, combination chemotherapy is performed for the treatment of lymphoma-associated autoimmune hematologic disorders and indeed seems to be effective. Our case indicates that corticosteroid monotherapy may be effective for lymphoma-associated AIN especially when AIN precedes the onset of lymphoma.

Entities:  

Keywords:  MALT lymphoma; autoimmune neutropenia; combination chemotherapy; corticosteroid; immune thrombocytopenia

Mesh:

Substances:

Year:  2014        PMID: 25337296      PMCID: PMC4203267     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  10 in total

1.  Successful treatment of non-Hodgkin's lymphoma complicated with autoimmune neutropenia.

Authors:  Nami Nakabe; Yutaka Kobayashi; Toshiki Nakajima; Takeshi Hattori; Junya Kuroda; Shinya Kimura; Toshikazu Yoshikawa
Journal:  Am J Hematol       Date:  2002-07       Impact factor: 10.047

2.  Idiopathic thrombocytopenic purpura in lymphoma.

Authors:  K Fink; H Al-Mondhiry
Journal:  Cancer       Date:  1976-04       Impact factor: 6.860

Review 3.  Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors:  Clive S Zent; Neil E Kay
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

4.  Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.

Authors:  Giovanni D'Arena; Luca Laurenti; Silvana Capalbo; Alfonso Maria D'Arco; Rosaria De Filippi; Gianpaolo Marcacci; Nicola Di Renzo; Sergio Storti; Catello Califano; Maria Luigia Vigliotti; Michela Tarnani; Felicetto Ferrara; Antonio Pinto
Journal:  Am J Hematol       Date:  2006-08       Impact factor: 10.047

Review 5.  Paraneoplastic autoimmune cytopenias in Hodgkin lymphoma.

Authors:  Klaus Lechner; Yen-An Chen
Journal:  Leuk Lymphoma       Date:  2010-03

Review 6.  How I treat autoimmune hemolytic anemias in adults.

Authors:  Klaus Lechner; Ulrich Jäger
Journal:  Blood       Date:  2010-06-14       Impact factor: 22.113

7.  Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin's disease.

Authors:  N Xiros; T Binder; B Anger; J Böhlke; H Heimpel
Journal:  Eur J Haematol       Date:  1988-05       Impact factor: 2.997

8.  Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.

Authors:  Alexander W Hauswirth; Cathrin Skrabs; Christian Schützinger; Markus Raderer; Andreas Chott; Peter Valent; Klaus Lechner; Ulrich Jäger
Journal:  Haematologica       Date:  2008-02-20       Impact factor: 9.941

9.  Helicobacter pylori and autoimmune neutropenia.

Authors:  V Gupta; A J Eden; M J Mills
Journal:  Clin Lab Haematol       Date:  2002-06

Review 10.  Primary and secondary autoimmune neutropenia.

Authors:  Franco Capsoni; Piercarlo Sarzi-Puttini; Alberto Zanella
Journal:  Arthritis Res Ther       Date:  2005-08-31       Impact factor: 5.156

  10 in total
  2 in total

1.  Immune pancytopenia after chemotherapy in a patient with diffuse large B-cell lymphoma.

Authors:  Kazuyo Nagashima; Hiroaki Tanaka; Yurie Nagai; Yasumasa Sugita
Journal:  BMJ Case Rep       Date:  2016-09-20

Review 2.  Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review.

Authors:  Yuya Kurihara; Kazuki Taoka; Eri Takagi; Kazuhiro Toyama; Kumi Nakazaki; Mineo Kurokawa
Journal:  Intern Med       Date:  2021-05-15       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.